MARKET

SNN

SNN

Smith & Nephew
NYSE
34.69
-0.48
-1.36%
After Hours: 34.30 -0.39 -1.12% 17:39 02/06 EST
OPEN
34.21
PREV CLOSE
35.17
HIGH
34.72
LOW
34.20
VOLUME
734.84K
TURNOVER
--
52 WEEK HIGH
38.47
52 WEEK LOW
23.71
MARKET CAP
14.74B
P/E (TTM)
31.06
1D
5D
1M
3M
1Y
5Y
1D
Smith+Nephew Sets 2 March 2026 Date for 2025 Full-Year Results
TipRanks · 3d ago
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga · 3d ago
Smith & Nephew Reports Routine Six-Month Update on Employee Share Schemes
TipRanks · 6d ago
Smith & Nephew Updates Share Capital and Voting Rights as of 31 January 2026
TipRanks · 6d ago
Weekly Report: what happened at SNN last week (0126-0130)?
Weekly Report · 6d ago
Smith & Nephew: Underappreciated Sports Medicine Growth Platforms Support Re‑Rating Potential and Justify Buy Rating
TipRanks · 01/26 12:07
Weekly Report: what happened at SNN last week (0119-0123)?
Weekly Report · 01/26 10:27
Smith & Nephew Executives Buy ADS under Employee Stock Purchase Plan
TipRanks · 01/23 14:47
More
About SNN
Smith & Nephew plc is a portfolio medical technology company. The Company is engaged in developing, manufacturing, marketing, and selling medical devices and services. It is focused on the repair, regeneration, and replacement of soft and hard tissue. The Company's segments include Orthopaedics, Sports Medicine & ENT and Advanced Wound Management. Its Orthopaedics segment includes a range of hip, knee and shoulder implants used to replace diseased, damaged or worn joints, robotics-assisted enabling technologies that empower surgeons, and trauma products used to stabilise severe fractures and correct bone deformities. Its Sports Medicine & Ear, Nose and Throat (ENT) businesses offer advanced products and instruments used to repair or remove soft tissue. Its Advanced Wound Management portfolio provides a comprehensive set of products to meet broad and complex clinical needs, and to help healthcare professionals reduce the human and economic consequences of wounds.

Webull offers Smith & Nephew PLC (ADR) stock information, including NYSE: SNN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SNN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SNN stock methods without spending real money on the virtual paper trading platform.